Stephen V Liu, MD (@stephenvliu) 's Twitter Profile
Stephen V Liu, MD

@stephenvliu

Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Co-Host @IASLC Podcast; Chair #TexasLung25 #DCLung25; #HereWeGo

ID: 377425889

linkhttps://www.medstarhealth.org/doctors/stephen-liu-md calendar_today21-09-2011 15:17:53

19,19K Tweet

26,26K Takipçi

3,3K Takip Edilen

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo
Stephen V Liu, MD
@stephenvliu

6 months ago

5 year outcomes with 1L cemiplimab vs chemo in PD-L1 high NSCLC from phase III EMPOWER-Lung 1 JTO & JTO CRR. OS favors cempilimab (26.1 vs 13.3m, HR 0.59, 5y OS rate 29% vs 15%) with better outcomes for PD-L1 ≥ 90%, where mOS 38.8m, 5y OS rate 39.8%. jto.org/article/S1556-…